Sign in
4

Changes in Ownership

TransMedics Group, Inc. Filed Acc 0000899243-22-027252

Chief Commercial Officer sold 13,504 shares at $40.01 ($540,295)

  • Chief Commercial Officer acquired 13,504 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Khayal Tamer I · Chief Commercial Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2022-07-29 Exercise or conversion : show line 1 in the form +5,681 $0.28 $1,591 51,757 D
2022-07-29 Exercise or conversion : show line 2 in the form +7,823 $2.21 $17,289 59,580 D
2022-07-29 Sale : show line 3 in the form −13,504 $40.01 $540,295 46,076 D
Open-market sales · 13,504 sh · avg $40.01 · $540,295

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2022-07-29 Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) −5,681 0 D
2022-07-29 Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) −7,823 41,051 D
Loading xslF345X03/doc4.xml…